We assist healthcare professionals in their decision-making through an AI health insight platform powered by proprietary Optomics® and multimodal biological data. We provide State-of-the-art technology for minimally invasive blood tests in drug development and clinical trial processes.

Specializing in complex diseases like Alzheimer’s, our platform aids in the precise identification of suitable clinical trial candidates, fostering the development of targeted, effective treatments.